Stevan David
Stevan David Jones, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20120009285 | Compositions for treating skin - A personal care composition comprising: at least a first phase and a second phase wherein said first phase comprises a) an aqueous structured surfactant phase comprising STnS where n is between about 0 and about 2.5; b) ; c) a structuring system comprising i. optionally, a non-ionic emulsifier; ii. optionally, from about 0.05% to about 5%, by weight of said personal care composition, of an associative polymer; iii. an electrolyte; and said second phase comprises a) a benefit phase comprising from 1% to about 50%, by weight of said personal care composition, of a hydrophobic benefit agent. | 01-12-2012 |
Stevan David Jones, Singapore SG
Patent application number | Description | Published |
---|---|---|
20130253057 | Personal Care Compositions and Methods - A personal care composition includes a cleansing phase and a benefit phase, the cleansing phase having a surfactant and the benefit phase having a lipid bilayer structurant. Methods to enhance skin hydration are also provided. | 09-26-2013 |
20140275184 | Cosmetic Compositions and Methods Providing Enhanced Penetration of Skin Care Actives - A cosmetic composition suitable for topical application is provided. In some examples, the cosmetic composition can include glycerin, hexyldecanol, a vitamin B compound, and one or more materials selected from the group consisting of 1,2-pentanediol, 1,4-pentanediol, 2,4-pentanediol, 1,5-pentanediol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 2,3-butanediol, 1,2-hexanediol, 1,5-hexanediol, 1,6-hexanediol, 2,5-hexanediol, hexylene glycol, and combinations thereof. | 09-18-2014 |
Stevan David Jones, Singparoe SG
Patent application number | Description | Published |
---|---|---|
20150305998 | COSMETIC COMPOSITIONS FOR HYDRATING SKIN - A cosmetic composition suitable for topical application is provided. The cosmetic composition comprises: a safe and effective amount of a humectant; a safe and effective amount of a lipid bilayer structurant, and a safe and effective amount of a chaotropic agent. The chaotropic agent denatures the cross-linked proteinaceous layer sitting immediately above skin thereby increasing the amount of humectant and lipid bilayer structurant that enters the stratum corneum; the humectant binds together with water molecules and the lipid bilayer structurant knits together the lipid bilayers of the stratum corneum thereby preventing water loss. | 10-29-2015 |